Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

J App Pharm Sci. 2017; 7(2): 067-075


Sequential optimizations of Aspergillus awamori EM66 exochitinase and its application as biopesticide

Ghada E. A. Awad, Walaa A. Abdel Wahab, Mona Hussein, Ahmed El-diwany, Mona A. Esawy.




Abstract

A sequential optimization strategy, based on statistical experimental designs was employed to enhance Aspergillus awamori EM66 exochitinase productivity. First, a 2-level Plackett–Burman design was applied to differentiate between the bioprocess parameters, which significantly influence exochitinase production. The second optimization step was performed using central composite design (CCD), in order to optimize variables amounts that have the highest positive significant effect on exochitinase production. A maximal activity (5998mU/ml) for exochitinase reported approximately 22 fold increase compared to the basal medium activity. Mortality 92%, 86.67% and 65.67% was recorded when the partial pure fungal exochitinase was applied to the diet of the greater wax moth larvae, Galleria mellonella, , the cotton leaf worm, Spodoptera littoralis, and the black cutworm, Agrotis ipsilon, respectively. The results indicated to the importance of Aspergillus awamori EM66 exochitinase as an effective biopesticide.

Key words: Aspergillus awamori; Bio pesticides; Central composite design; Exochitinase






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.